RARA CRAFT DATABASE for FDA Medical Devices
De NovoDEN220027

FDA DEVICE FACTS

B·R·A·H·M·S sFlt-1/ PlGF KRYPTOR Test Sy

Brahms GmbH, Part of Thermo Fisher Scien

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATE05/18/2023PRODUCT CODEQWH

Indications for use

The B·R·A·H·M·S TM sFlt-1/ PlGF KRYPTORTM Test System is comprised of the B·R·A·H·M·S PlGF plus KRYPTOR assay and the B·R·A·H·M·S sFlt-1 KRYPTOR assay. The B·R·A·H·M·S PlGF plus KRYPTOR is an automated immunofluorescent assay using Time-Resolved Amplified Cryptate Emission (TRACE TM) technology for the quantitative determination of the concentration of Placental Growth Factor (PlGF) in human serum and plasma (K2 EDTA) on the B·R·A·H·M·S KRYPTOR analyzer. The B·R·A·H·M·S sFlt-1 KRYPTOR is an automated immunofluorescent assay using Time- Resolved Amplified Cryptate Emission (TRACE) technology for the quantitative determination of the concentration of soluble fms-like tyrosine kinase-1 (sFlt-1), also known as VEGF receptor-1, in human serum and plasma (K2 EDTA) on the B·R·A·H·M·S KRYPTOR analyzer. The B·R·A·H·M·S PlGF plus KRYPTOR is to be used in conjunction with the B·R·A·H·M·S sFlt-1 KRYPTOR along with other laboratory tests and clinical assessments to aid in the risk assessment of pregnant women (singleton pregnancies between gestational age 23+0 to 34+6/7 weeks) hospitalized for hypertensive disorders of pregnancy (preeclampsia, chronic hypertension with or without superimposed preeclampsia, or gestational hypertension) for progression to preeclampsia with severe features (as defined by the American College of Obstetricians and Gynecologists (ACOG) guidelines) within 2 weeks of presentation.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026